Diabetes 54:S73-S78, 2005
© 2005 by the American Diabetes Association, Inc.
Section III: Inflammation and ß-Cell Death |
Role of Endoplasmic Reticulum Stress and c-Jun NH2-Terminal Kinase Pathways in Inflammation and Origin of Obesity and Diabetes
Gökhan S. Hotamisligil
From the Departments of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts
Metabolic and immune systems are the most fundamental requirements for survival, and many metabolic and immune response pathways or nutrient- and pathogen-sensing systems have been evolutionarily highly conserved. Consequently, metabolic and immune pathways are also highly integrated and interdependent. In the past decade, it became apparent that this interface plays a critical role in the pathogenesis of chronic metabolic diseases, particularly obesity and type 2 diabetes. Importantly, the inflammatory component in obesity and diabetes is now firmly established with the discovery of causal links between inflammatory mediators, such as tumor necrosis factor (TNF)- and insulin receptor signaling and the elucidation of the underlying molecular mechanisms, such as c-Jun NH2-terminal kinase (JNK)- and inhibitor of nuclear factor- B kinase–mediated transcriptional and posttranslational modifications that inhibit insulin action. More recently, obesity-induced endoplasmic reticulum stress has been demonstrated to underlie the initiation of obesity-induced JNK activation, inflammatory responses, and generation of peripheral insulin resistance. This article will review the link between stress, inflammation, and metabolic disease, particularly type 2 diabetes, and discuss the mechanistic and therapeutic opportunities that emerge from this platform by focusing on JNK and endoplasmic reticulum stress responses.
Address correspondence and reprint requests to Gökhan S. Hotamisligil, MD, PhD, 665 Huntington Ave., Bldg. I, Rm. 205, Boston, MA 02115. E-mail: ghotamis{at}hsph.harvard.edu
Abbreviations:
ER, endoplasmic reticulum; IKK, inhibitor of nuclear factor- B kinase; IRS, insulin receptor substrate; JIP, JNK-interacting protein; JNK, c-Jun NH2 terminal kinase; TNF, tumor necrosis factor

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Xu, A. W.K. Tso, B. M.Y. Cheung, Y. Wang, N. M.S. Wat, C. H.Y. Fong, D. C.Y. Yeung, E. D. Janus, P. C. Sham, and K. S.L. Lam
Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict the Development of the Metabolic Syndrome: A 5-Year Prospective Study
Circulation,
March 27, 2007;
115(12):
1537 - 1543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Bogoyevitch and B. Kobe
Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases
Microbiol. Mol. Biol. Rev.,
December 1, 2006;
70(4):
1061 - 1095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Alquier, C. Leloup, A. Lorsignol, and L. Penicaud
Translocable Glucose Transporters in the Brain: Where Are We in 2006?
Diabetes,
December 1, 2006;
55(Supplement_2):
S131 - S138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. TELI, D. XANTHAKI, and K. P KARALIS
Regulation of Appetite and Insulin Signaling in Inflammatory States
Ann. N.Y. Acad. Sci.,
November 1, 2006;
1083(1):
319 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tuncman, J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G. S. Hotamisligil
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
PNAS,
July 11, 2006;
103(28):
10741 - 10746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian, M. B. Katan, A. Ascherio, M. J. Stampfer, and W. C. Willett
Trans Fatty Acids and Cardiovascular Disease
N. Engl. J. Med.,
April 13, 2006;
354(15):
1601 - 1613.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|